Open AccessPharmacokinetics of inhaled colistin in patients with cystic fibrosis
Author(s) -
Félix Ratjen,
E. Rietschel,
Dirk Kasel,
Raphael Schwiertz,
Kathrin Starke,
Horst Beier,
Silvana van Koningsbruggen,
Hartmut Grasemann
Publication year - 2006
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dki461
Subject(s) - colistin , sputum , medicine , cystic fibrosis , pharmacokinetics , urine , inhalation , cmax , nebulizer , pharmacology , pseudomonas aeruginosa , gastroenterology , antibiotics , anesthesia , microbiology and biotechnology , pathology , tuberculosis , biology , bacteria , genetics
Inhaled colistin is commonly used in patients with cystic fibrosis (CF), but only limited data are available to define its pharmacokinetic profile.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom